๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

O297 Development of recombinant antibody therapeutics for the treatment of bacterial infections

โœ Scribed by I.D. Broadbent; K.A. Charlton; G. Strachan; S.J. Williams; J. Steven; J. Park; C.J. Barelle; D.P. McGregor; A.J.R. Porter

Book ID
119564340
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
51 KB
Volume
29
Category
Article
ISSN
0924-8579

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Development of Antibody-Based Therapeuti
Development of Antibody-Based Therapeutics || Technologies for the Generation of Human Antibodies
โœ Tabrizi, Mohammad A.; Bornstein, Gadi G.; Klakamp, Scott L. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Springer New York ๐ŸŒ English โš– 881 KB

The biologics market continues to witness an impressive rate of growth and the monoclonal antibody market, in particular, has contributed remarkably to the expansion of this segment within the pharmaceutical industry. In 2006, close to 80% of the annual biologics growth rate in the United States (US